Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 5
2020 2
2021 4
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Safety trial of tadalafil administered for the treatment of preeclampsia.
Furuhashi FH, Tanaka H, Kaneda MK, Maki S, Nii M, Umekawa T, Osato K, Kamimoto Y, Ikeda T. Furuhashi FH, et al. Among authors: kaneda mk. J Matern Fetal Neonatal Med. 2020 Jan;33(1):167-170. doi: 10.1080/14767058.2018.1487946. Epub 2018 Jul 22. J Matern Fetal Neonatal Med. 2020. PMID: 29886797 Clinical Trial.
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.
Ito K, Nakagawa M, Shimokawa M, Hori K, Tashima L, Goto M, Yanagida S, Suzuki J, Kaya R, Kawabata A, Yamada K, Park J, Nasu H, Nishio S, Kondo E, Kaneda M, Tsubamoto H, Arakawa A, Nagasawa T, Motohashi T. Ito K, et al. Among authors: kaneda m. Anticancer Drugs. 2023 Aug 1;34(7):857-865. doi: 10.1097/CAD.0000000000001472. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729915 Clinical Trial.
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD. Matsuo K, et al. Among authors: kaneda m. Gynecol Oncol. 2019 Oct;155(1):39-50. doi: 10.1016/j.ygyno.2019.08.007. Epub 2019 Aug 16. Gynecol Oncol. 2019. PMID: 31427143 Free PMC article.
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial.
Furuhashi F, Tanaka H, Maki S, Tsuji M, Magawa S, Kaneda MK, Nii M, Tanaka K, Ogura T, Nishimura Y, Endoh M, Kimura T, Kotani T, Sekizawa A, Ikeda T; MIE Study Group. Furuhashi F, et al. Among authors: kaneda mk. J Matern Fetal Neonatal Med. 2021 Nov;34(22):3709-3715. doi: 10.1080/14767058.2019.1690447. Epub 2019 Nov 17. J Matern Fetal Neonatal Med. 2021. PMID: 31736381 Clinical Trial.
Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
Tachibana R, Umekawa T, Yoshikawa K, Owa T, Magawa S, Furuhashi F, Tsuji M, Maki S, Shimada K, Kaneda MK, Nii M, Tanaka H, Tanaka K, Kamimoto Y, Kondo E, Kato I, Ikemura K, Okuda M, Ma N, Miyoshi T, Hosoda H, Endoh M, Kimura T, Ikeda T. Tachibana R, et al. Among authors: kaneda mk. Sci Rep. 2019 Jan 18;9(1):234. doi: 10.1038/s41598-018-36084-x. Sci Rep. 2019. PMID: 30659198 Free PMC article.
12 results